$0.859400
0.022.66%
Pre-Market: 5:54 PM EDT
15 minutes delayed
Comments
Loading...
Sangamo Therapeutics (SGMO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSangamo Therapeutics (NASDAQ:SGMO) Stock Quotes, Forecast and News Summary
Sangamo Therapeutics Stock (NASDAQ: SGMO) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 14.40M |
| Day Range | - - - |
| 52 Wk Range | 0.29 - 1.48 |
| Market Cap | $178.94M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 54 |
| Short Interest | 8.68% |
| Days to Cover | 3.92 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Sangamo Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking scie...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sangamo Therapeutics (SGMO) stock?
You can purchase shares of Sangamo Therapeutics (NASDAQ:SGMO) through any online brokerage.
Who are Sangamo Therapeutics (SGMO) competitors?
Other companies in Sangamo Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), Cabaletta Bio (NASDAQ:CABA) and Skye Bioscience (NASDAQ:SKYE).
What is the forecast, or price target, for Sangamo Therapeutics (SGMO) stock?
Sangamo Therapeutics has a consensus price target of $4.64.
What is the current price for Sangamo Therapeutics (SGMO)?
The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $0.8594 last updated September 18, 2024 at 5:54 PM EDT.
Does Sangamo Therapeutics (SGMO) pay a dividend?
There are no upcoming dividends for Sangamo Therapeutics.
When is Sangamo Therapeutics (NASDAQ:SGMO) reporting earnings?
Sangamo Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
Is Sangamo Therapeutics (SGMO) going to split?
There is no upcoming split for Sangamo Therapeutics.
What sector and industry does Sangamo Therapeutics (SGMO) operate in?
Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.